Heart Health
Pfizer's PCSK9 Inhibitor Bococizumab Put to the Test in High-Risk Hyperlipidemia
A Phase 3 trial examines whether bococizumab slashes LDL in statin-treated patients at elevated cardiovascular risk.
Clinical Trial
Jun 8, 2026 0
Results for "BPC-157 Peptide" in Heart Disease
20 articles
Heart Health
Chinese PCSK9 Inhibitor Trial Tests IBI306 for High-Risk Cholesterol Patients
Phase 3 trial of IBI306, a PCSK9 inhibitor, tests LDL-C reduction in Chinese adults with high cardiovascular risk on statin therapy.
Clinical Trial
Jun 7, 2026 0
Heart Health
New Dual-Target Cancer Drug Eliminates Pancreatic Tumors With Single Low Dose
Revolutionary nanobody drug targets two proteins simultaneously, achieving complete tumor elimination in preclinical studies.
Research Paper
Mar 28, 2026 1
Heart Health
First Oral PCSK9 Inhibitor MK-0616 Shows Promise for Cholesterol Management
New oral drug MK-0616 matches injectable PCSK9 inhibitors for lowering LDL cholesterol while offering patient-friendly pill form.
Research Paper
Apr 7, 2026 0
Heart Health
Single Protein PHF7 Repairs Hearts After Heart Attack by Converting Scar Tissue
Breakthrough study shows one epigenetic factor can transform cardiac fibroblasts into heart muscle cells, improving function after myocardial infarction.
Research Paper
Apr 3, 2026 0
Heart Health
PCSK9 Inhibitors Cut Heart Disease Risk by 40% Over Three Years in High-Risk Patients
New study shows PCSK9 monoclonal antibodies dramatically reduce cardiovascular events and hospitalizations in very high-risk patients.
Research Paper
Mar 28, 2026 1
Heart Health
Breast Cancer Treatment Uncovers Hidden BMPR2 Risk for Pulmonary Hypertension
A correction to a landmark study linking breast cancer to latent BMPR2-driven pulmonary hypertension susceptibility in Circulation.
Research Paper
May 27, 2026 0
Heart Health
New PCSK9 Inhibitors Could Revolutionize Heart Disease Prevention and Longevity
Advanced cholesterol-lowering therapies show promise for dramatically reducing cardiovascular disease risk through innovative approaches.
Research Paper
Mar 28, 2026 0
Heart Health
Pelacarsen Targets Lp(a) in Black and Hispanic Americans With Heart Disease
A completed Phase IIIb trial tests whether pelacarsen can safely lower Lp(a) in historically underrepresented cardiovascular disease populations.
Clinical Trial
May 27, 2026 0
Heart Health
Tirzepatide Delivers Sweeping Cardiometabolic Benefits Beyond Weight Loss
A comprehensive review reveals tirzepatide improves blood pressure, lipids, liver fat, kidney function, and slashes 10-year cardiovascular risk by up to 23.5%.
Research Paper
May 30, 2026 0
Heart Health
Blocking Key Protein Delays Obesity and Metabolic Disease in Early Stages
New research reveals how eliminating urokinase plasminogen activator can temporarily protect against diet-induced weight gain and metabolic dysfunction.
Research Paper
Mar 29, 2026 1
Heart Health
Scientists Develop First Small-Molecule Activators for Heart-Protective PAK1 Kinase
Breakthrough discovery of PAK1 kinase activators shows promise for treating cardiac hypertrophy and heart failure through targeted enzyme enhancement.
Research Paper
Apr 3, 2026 0
Heart Health
First Oral PCSK9 Inhibitor Cuts LDL Cholesterol by 80% in Phase 1 Trial
Laroprovstat, a once-daily pill, slashed LDL by 80% when combined with rosuvastatin โ rivaling injectable PCSK9 inhibitors.
Research Paper
May 16, 2026 0
Heart Health
New Antibody Drug Slashes Dangerous Cholesterol by 59% in Genetic Disorder
SHR-1918 antibody dramatically reduced LDL cholesterol in patients with severe genetic hypercholesterolemia through novel pathway.
Research Paper
Mar 29, 2026 1
Heart Health
Elamipretide Wins First FDA Approval for Barth Syndrome Via Mitochondrial Repair
The first disease-specific treatment for Barth syndrome gains FDA accelerated approval, targeting mitochondrial dysfunction to restore muscle strength.
Research Paper
May 20, 2026 0
Heart Health
Heart Enzyme PYGM Shields Against Heart Attack by Boosting Energy and Autophagy
A muscle enzyme that declines in heart attack patients may hold the key to preserving cardiac function after MI.
Research Paper
May 21, 2026 0
Heart Health
Thymosin Alpha-1 Tested to Prevent Organ Failure After Emergency Aortic Surgery
A 330-patient multicenter RCT tests whether thymosin ฮฑ1 can curb immune dysregulation and organ dysfunction after acute type A aortic dissection repair.
Research Paper
Apr 27, 2026 0
Heart Health
Bempedoic Acid Cuts Venous Clot Risk by 42% in Statin-Intolerant Patients
A post hoc analysis of the CLEAR Outcomes trial finds bempedoic acid significantly reduces DVT and pulmonary embolism risk.
Research Paper
May 29, 2026 0
Heart Health
New PCSK9 Inhibitor Recaticimab Slashes Bad Cholesterol by 53mg/dL in Clinical Trials
Meta-analysis shows recaticimab dramatically reduces LDL cholesterol and other cardiovascular risk markers with manageable side effects.
Research Paper
Mar 28, 2026 0
Heart Health
Olpasiran Slashes Lp(a) Levels in Phase 2 Cardiovascular Trial
Amgen's siRNA therapy olpasiran targets lipoprotein(a), a stubborn cardiovascular risk factor with no approved treatments.
Clinical Trial
Jun 14, 2026 0
Page 1 of 2Next